ID: ALA4580788
Chembl Id: CHEMBL4580788
PubChem CID: 155561303
Max Phase: Preclinical
Molecular Formula: C16H13ClN2O
Molecular Weight: 284.75
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1ccc2cc(COc3ccc(Cl)cc3)ccc2n1
Standard InChI: InChI=1S/C16H13ClN2O/c17-13-3-5-14(6-4-13)20-10-11-1-7-15-12(9-11)2-8-16(18)19-15/h1-9H,10H2,(H2,18,19)
Standard InChI Key: SJBGPTUSTLFHLR-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 284.75 | Molecular Weight (Monoisotopic): 284.0716 | AlogP: 4.05 | #Rotatable Bonds: 3 |
| Polar Surface Area: 48.14 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: 6.11 | CX LogP: 4.07 | CX LogD: 4.05 |
| Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.79 | Np Likeness Score: -0.71 |
| 1. Solbak SMØ, Zang J, Narayanan D, Høj LJ, Bucciarelli S, Softley C, Meier S, Langkilde AE, Gotfredsen CH, Sattler M, Bach A.. (2020) Developing Inhibitors of the p47phox-p22phox Protein-Protein Interaction by Fragment-Based Drug Discovery., 63 (3): [PMID:31922756] [10.1021/acs.jmedchem.9b01492] |
Source(1):
